Discovery of dachshund 2 protein as a novel biomarker of poor prognosis in epithelial ovarian cancer

Journal of Ovarian Research

Volumn 5, Issue 1, 2012, Pages

  Nodin, Björn ^a   Fridberg, Marie ^a   Uhlén, Mathias ^b,c   Jirström, Karin ^a  

^a LUND UNIVERSITY   (Sweden)

^b ALBANOVA UNIVERSITY CENTER   (Sweden)

^c ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

Author keywords

DACH2; ovarian cancer; prognosis

Indexed keywords

CISPLATIN; DACHSHUND 2 PROTEIN; PACLITAXEL; PROTEIN; PROTEIN ANTIBODY; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CELL CULTURE; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; DRUG SENSITIVITY; EPITHELIAL OVARY CANCER; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY CANCER; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY; UTERINE TUBE TUMOR;

EID: 84856153519     PISSN: None     EISSN: 17572215     Source Type: Journal    
DOI: 10.1186/1757-2215-5-6     Document Type: Article

References (30)

1. Cancer statistics, 2009. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ, CA Cancer J Clin 2009 59 4 225 249 10.3322/caac.20006 19474385
2. Ovarian cancer. Hennessy BT, Coleman RL, Markman M, Lancet 2009 374 9698 1371 1382 10.1016/S0140-6736(09)61338-6 19793610
3. The Human Protein Atlas - a tool for pathology. Ponten F, Jirstrom K, Uhlen M, J Pathol 2008 216 4 387 393 10.1002/path.2440 18853439
4. A web-based tool for in silico biomarker discovery based on tissue-specific protein profiles in normal and cancer tissues. Bjorling E, Lindskog C, Oksvold P, Linne J, Kampf C, Hober S, Uhlen M, Ponten F, Mol Cell Proteomics 2008 7 5 825 844 10.1074/mcp.M700411-MCP200 17913849 (Pubitemid 351737085)
5. The Drosophila sex determination hierarchy modulates wingless and decapentaplegic signaling to deploy dachshund sex-specifically in the genital imaginal disc. Keisman EL, Baker BS, Development 2001 128 9 1643 1656 11290302 (Pubitemid 32514847)
6. Dachshund encodes a nuclear protein required for normal eye and leg development in Drosophila. Mardon G, Solomon NM, Rubin GM, Development 1994 120 12 3473 3486 7821215 (Pubitemid 24366992)
7. Mouse Dach, a homologue of Drosophila dachshund, is expressed in the developing retina, brain and limbs. Davis RJ, Shen W, Heanue TA, Mardon G, Development genes and evolution 1999 209 9 526 536 10.1007/s004270050285 10502109 (Pubitemid 29452697)
8. Molecular cloning and expression of the human and mouse homologues of the Drosophila dachshund gene. Kozmik Z, Pfeffer P, Kralova J, Paces J, Paces V, Kalousova A, Cvekl A, Development genes and evolution 1999 209 9 537 545 10.1007/s004270050286 10502110 (Pubitemid 29452698)
9. Dach1, a vertebrate homologue of Drosophila dachshund, is expressed in the developing eye and ear of both chick and mouse and is regulated independently of Pax and Eya genes. Heanue TA, Davis RJ, Rowitch DH, Kispert A, McMahon AP, Mardon G, Tabin CJ, Mechanisms of development 2002 111 1-2 75 87 10.1016/S0925-4773(01)00611-6 11804780 (Pubitemid 34136980)
10. Characterization of mouse Dach2, a homologue of Drosophila dachshund. Davis RJ, Shen W, Sandler YI, Heanue TA, Mardon G, Mechanisms of development 2001 102 1-2 169 179 10.1016/S0925-4773(01)00307-0 11287190 (Pubitemid 32273595)
11. Mouse Dach1 and Dach2 are redundantly required for Mullerian duct development. Davis RJ, Harding M, Moayedi Y, Mardon G, Genesis 2008 46 4 205 213 10.1002/dvg.20385 18395837 (Pubitemid 351703373)
12. Most X;autosome translocations associated with premature ovarian failure do not interrupt X-linked genes. Prueitt RL, Chen H, Barnes RI, Zinn AR, Cytogenet Genome Res 2002 97 1-2 32 38 10.1159/000064052 12438735 (Pubitemid 37499876)
13. Mutation analysis of two candidate genes for premature ovarian failure, DACH2 and POF1B. Bione S, Rizzolio F, Sala C, Ricotti R, Goegan M, Manzini MC, Battaglia R, Marozzi A, Vegetti W, Dalpra L, et al. Hum Reprod 2004 19 12 2759 2766 10.1093/humrep/deh502 15459172 (Pubitemid 40028944)
14. The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling. Popov VM, Zhou J, Shirley LA, Quong J, Yeow WS, Wright JA, Wu K, Rui H, Vadlamudi RK, Jiang J, et al. Cancer Res 2009 69 14 5752 5760 10.1158/0008-5472.CAN-08-3992 19605405
15. The cell fate determination factor dachshund inhibits androgen receptor signaling and prostate cancer cellular growth. Wu K, Katiyar S, Witkiewicz A, Li A, McCue P, Song LN, Tian L, Jin M, Pestell RG, Cancer Res 2009 69 8 3347 3355 10.1158/0008-5472.CAN-08-3821 19351840
16. Altered expression of DACH1 and cyclin D1 in endometrial cancer. Nan F, Lu Q, Zhou J, Cheng L, Popov VM, Wei S, Kong B, Pestell RG, Lisanti MP, Jiang J, et al. Cancer Biol Ther 2009 8 16 1534 1539 10.4161/cbt.8.16.8963 19502783
17. Identification of prognostic biomarkers in gastric cancer using endoscopic biopsy samples. Yamada Y, Arao T, Gotoda T, Taniguchi H, Oda I, Shirao K, Shimada Y, Hamaguchi T, Kato K, Hamano T, et al. Cancer Sci 2008 99 11 2193 2199 10.1111/j.1349-7006.2008.00935.x 18957060
18. Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta signaling in ovarian cancer. Sunde JS, Donninger H, Wu K, Johnson ME, Pestell RG, Rose GS, Mok SC, Brady J, Bonome T, Birrer MJ, Cancer Res 2006 66 17 8404 8412 10.1158/0008-5472.CAN-06-0683 16951150 (Pubitemid 44449151)
19. DACH1 is a cell fate determination factor that inhibits cyclin D1 and breast tumour growth. Wu K, Li A, Rao M, Liu M, Dailey V, Yang Y, Di Vizio D, Wang C, Lisanti MP, Sauter G, et al. Mol Cell Biol 2006 26 19 7116 7129 10.1128/MCB.00268-06 16980615 (Pubitemid 44479729)
20. The Malmo Diet and Cancer Study. Design and feasibility. Berglund G, Elmstahl S, Janzon L, Larsson SA, J Intern Med 1993 233 1 45 51 10.1111/j.1365-2796.1993.tb00647.x 8429286
21. Cardiovascular risk groups and mortality in an urban swedish male population: the Malmo Preventive Project. Berglund G, Eriksson KF, Israelsson B, Kjellstrom T, Lindgarde F, Mattiasson I, Nilsson JA, Stavenow L, J Intern Med 1996 239 6 489 497 10.1046/j.1365-2796.1996.483819000.x 8656142
22. Increased androgen receptor expression in serous carcinoma of the ovary is associated with an improved survival. Nodin B, Zendehrokh N, Brandstedt J, Nilsson E, Manjer J, Brennan DJ, Jirstrom K, J Ovarian Res 3 14
23. Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer. Ehlen A, Brennan DJ, Nodin B, O'Connor DP, Eberhard J, Alvarado-Kristensson M, Jeffrey IB, Manjer J, Brandstedt J, Uhlen M, et al. J Transl Med 8 78
24. RBM3-regulated genes promote DNA integrity and affect clinical outcome in epithelial ovarian cancer. Ehlen A, Nodin B, Rexhepaj E, Brandstedt J, Uhlen M, Alvarado-Kristensson M, Ponten F, Brennan DJ, Jirstrom K, Translational oncology 2011 4 4 212 221 21804916
25. Tissue microarrays for high-throughput molecular profiling of tumour specimens. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP, Nat Med 1998 4 7 844 847 10.1038/nm0798-844 9662379 (Pubitemid 28331029)
26. Cell-cycle checkpoints and cancer. Kastan MB, Bartek J, Nature 2004 432 7015 316 323 10.1038/nature03097 15549093 (Pubitemid 39551659)
27. MCM proteins: DNA damage, mutagenesis and repair. Bailis JM, Forsburg SL, Current opinion in genetics & development 2004 14 1 17 21 10.1016/j.gde.2003.11.002 22280100 (Pubitemid 38167473)
28. The cell of origin of ovarian epithelial tumours. Dubeau L, Lancet Oncol 2008 9 12 1191 1197 10.1016/S1470-2045(08)70308-5 19038766
29. Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention. Carlson JW, Miron A, Jarboe EA, Parast MM, Hirsch MS, Lee Y, Muto MG, Kindelberger D, Crum CP, J Clin Oncol 2008 26 25 4160 4165 10.1200/JCO.2008.16.4814 18757330
30. A candidate precursor to serous carcinoma that originates in the distal fallopian tube. Lee Y, Miron A, Drapkin R, Nucci MR, Medeiros F, Saleemuddin A, Garber J, Birch C, Mou H, Gordon RW, et al. J Pathol 2007 211 1 26 35 10.1002/path.2091 17117391 (Pubitemid 46092026)